Multidrug resistant Acinetobacter screen (multidrug resistant resistance)

Microbiology

Notes

Multidrug resistant Acinetobacter species are defined as strains showing resistance to quinolones, cephalosporins, gentamicin, co-amoxiclav and piperacillin/tazobactam. They may also be resistant to carbapenems and colistin.

• All patients seen by the preassessment team should have a clinical risk assessment to determine those at higher risk of MRAB
• The following sites should be screened:
  • Nose
  • Throat
  • Groin
  • Urine (MSU or CSU)
  • Sputum (if productive)
  • Stool (or rectal swab)
  • Wounds
• For further guidance and information please see Trust protocol - MULTI-DRUG RESISTANT BACTERIA (EXCLUDING MRSA) AND OTHER ALERT ORGANISMS: MANAGEMENT OF INFECTED OR COLONISED PATIENTS (Action card 7)

Sample requirements

Nose, thoat, groin, wound and rectal swabs

Standard charcoal transport swab

Place swab in transport medium

Stool samples

Stool container with spoon

Sputum samples

60 mL wide-mouthed container

Urine samples may be sent in either red or white capped 30 mL sterile universal containers.

Required information

• Reason for screening (e.g. transfer) and location of transferring hospital
• If testing is required for another healthcare provider

Storage/transport

Store and transport at room temperature

Turnaround time

Negative: 1-2 days

Positive: 2-3 days